InPlay Oil Corp
IPO-T
13 watching
0
0
0
0
0
Your Reaction
They are in the Cardium formation. They sold a non-core asset and will use the proceeds to accelerate their Cardium program. He expects production to rise from 4900 to 5100 boe by the end of the year. Cash flow this year was about 53 cents. The balance sheet is in good shape. His 12-month price target is $3.60. Yield 0%.(Analysts’ price target is $2.92)
They are in the Cardium formation. They sold a non-core asset and will use the proceeds to accelerate their Cardium program. He expects production to rise from 4900 to 5100 boe by the end of the year. Cash flow this year was about 53 cents. The balance sheet is in good shape. His 12-month price target is $3.60. Yield 0%.(Analysts’ price target is $2.92)
(A Top Pick April 7/17 Down 31%). This is a Cardium oil play and should exit 2018 at 4800 boed. He likes the leadership. He would buy this at $1.44 and continues to wait to buy on weakness.
(A Top Pick April 7/17 Down 31%). This is a Cardium oil play and should exit 2018 at 4800 boed. He likes the leadership. He would buy this at $1.44 and continues to wait to buy on weakness.
He likes it. 72% is oil and liquids. They have a nice land spread and they have land value appreciation already. They know what they are doing.
He likes it. 72% is oil and liquids. They have a nice land spread and they have land value appreciation already. They know what they are doing.
The $1.66 level is quite interesting. Once it gets by that, the next level would be the high $1.90 area. It has just got above its 200-day moving average, which is reasonably positive.
The $1.66 level is quite interesting. Once it gets by that, the next level would be the high $1.90 area. It has just got above its 200-day moving average, which is reasonably positive.
(A Top Pick Apr 7/17, Down 22%) They have done a great job. They are completing their current well in Q2. He recommends buying it on weakness.
(A Top Pick Apr 7/17, Down 22%) They have done a great job. They are completing their current well in Q2. He recommends buying it on weakness.
This is a smaller company. A Cardium player in Western Canada. They have a good team. It is currently doing 3600 BOE’s a day and will be north of 4000-4200 by the end of the year. His 12-month target is $3.60. BV is $3. How many times do you buy a good growing company with a good balance sheet that is trading below BV? (Analysts price target is $3.25.)
This is a smaller company. A Cardium player in Western Canada. They have a good team. It is currently doing 3600 BOE’s a day and will be north of 4000-4200 by the end of the year. His 12-month target is $3.60. BV is $3. How many times do you buy a good growing company with a good balance sheet that is trading below BV? (Analysts price target is $3.25.)
Comments
- «
- ‹
- 1
- ›
- »
00000